Thompson Bithika
1 Division of Endocrinology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
J Diabetes Sci Technol. 2018 Nov;12(6):1200-1202. doi: 10.1177/1932296818799363. Epub 2018 Sep 12.
In this article in JDST, Feuerstein-Simon and colleagues examine use of a smartphone app in improving hypoglycemia awareness in type 1 diabetes (T1D). They conclude that their smartphone app, HypoMap™, has the potential to increase hypoglycemia awareness and reduce time spent with hypoglycemia in a cohort of long-standing patients with type 1 diabetes. The underlying assumption is that if patients can identify the precipitating cause, they can recognize symptoms better and potentially change behavior to prevent future hypoglycemic events. Potential limitations of this intervention include technical issues, patient burden from data entry with use of an app, and concern that this type of intervention may not be sustainable over time. While results of this pilot study suggest HypoMap may be an effective intervention in preventing hypoglycemia, further studies of increased sample size are needed to confirm these findings.
在发表于《糖尿病科学与技术杂志》(JDST)的这篇文章中,费尔斯坦 - 西蒙及其同事研究了一款智能手机应用程序在提高1型糖尿病(T1D)患者低血糖意识方面的应用。他们得出结论,他们的智能手机应用程序HypoMap™有潜力提高长期1型糖尿病患者群体的低血糖意识,并减少低血糖持续时间。其潜在假设是,如果患者能够识别诱发原因,他们就能更好地识别症状,并有可能改变行为以预防未来的低血糖事件。这种干预措施的潜在局限性包括技术问题、使用应用程序进行数据录入给患者带来的负担,以及担心随着时间推移这种干预措施可能无法持续。虽然这项初步研究的结果表明HypoMap可能是预防低血糖的有效干预措施,但需要进一步扩大样本量的研究来证实这些发现。